CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 454,545 shares at $11.00 ($4,999,995)
- 4 Open-market buy 10% owner bought 700,000 shares at $11.00 ($7,700,000)
- SC 13G Stake Amended Statement of Ownership
- 4 Conversion Director acquired 18,144 shares (conversion)
- 4 Conversion President & CEO acquired 60,483 shares (conversion)
- 8-K Event Bylaws or fiscal year change
- 4 Conversion 10% owner acquired 696,378 shares (conversion)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
Page 21 of 23 · 452 filings